Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Gosselin
Benoît Gosselin, Tavaux FR
| Patent application number | Description | Published |
|---|---|---|
| 20090270588 | PROCESS FOR PRODUCING DICHLOROPROPANOL - Process for producing dichloropropanol wherein glycerol is reacted with at least one chlorinating agent in a reactor made of or coated with materials selected from enamelled steel, polyolefins, fluorinated polymers, phenolic resins, tantalum, and silver. | 10-29-2009 |
| 20090275726 | PROCESS FOR PRODUCING EPICHLOROHYDRIN - Process for producing epichlorohydrin comprising subjecting to a dehydrochlorination operation, dichloropropanol produced from glycerol comprising aldehydes. | 11-05-2009 |
Benoît Gosselin, Tavaux FR
| Patent application number | Description | Published |
|---|---|---|
| 20090275726 | PROCESS FOR PRODUCING EPICHLOROHYDRIN - Process for producing epichlorohydrin comprising subjecting to a dehydrochlorination operation, dichloropropanol produced from glycerol comprising aldehydes. | 11-05-2009 |
Florian Gosselin, Vanves FR
| Patent application number | Description | Published |
|---|---|---|
| 20090260473 | Jointed Limb Comprising Fibres, and Jointed Structure and Robot or Haptic Interface Comprising Such a Jointed Limb - The primary object of the present invention is a jointed and instrumented limb for robot or haptic interface comprising at least first ( | 10-22-2009 |
Gilles Gosselin, Monpellier FR
| Patent application number | Description | Published |
|---|---|---|
| 20100316594 | MODIFIED 2' AND 3' NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS - 2′ and/or 3′ prodrugs of 1′, 2′, 3′ or 4′-branched nucleosides, and their pharmaceutically acceptable salts and derivatives are described. These prodrugs are useful in the prevention and treatment of Flaviviridae infections, including HCV infection, and other related conditions. Compounds and compositions of the prodrugs of the present invention are described. Methods and uses are also provided that include the administration of an effective amount of the prodrugs of the present invention, or their pharmaceutically acceptable salts or derivatives. These drugs may optionally be administered in combination or alteration with further anti-viral agents to prevent or treat Flaviviridae infections and other related conditions. | 12-16-2010 |